MALLORY/HEAD PF RASP/PROV. 104467

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 06,07 report with the FDA on 2002-02-14 for MALLORY/HEAD PF RASP/PROV. 104467 manufactured by Biomet, Inc..

Event Text Entries

[17114726] It was reported that during total hip arthroplasty in 2001, trunion of instrument fractured. Lateral edge of femur was notched to facilitate removal.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1825034-2002-00016
MDR Report Key377454
Report Source06,07
Date Received2002-02-14
Date of Report2002-02-13
Date of Event2000-10-02
Date Mfgr Received2002-01-18
Device Manufacturer Date1997-05-01
Date Added to Maude2002-02-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional0
Initial Report to FDA0
Report to FDA0
Event Location0
Manufacturer ContactBETH ALBERT, AST.
Manufacturer StreetP.O. BOX 587
Manufacturer CityWARSAW IN 465810587
Manufacturer CountryUS
Manufacturer Postal465810587
Manufacturer Phone5742676639
Manufacturer G1*
Manufacturer Street*
Manufacturer City*
Manufacturer Country*
Single Use3
Previous Use Code3
Removal Correction NumberNOT APPLICABLE
Event Type3
Type of Report3

Device Details

Brand NameMALLORY/HEAD PF RASP/PROV.
Generic NameRASP/PROVISIONAL
Product CodeGAC
Date Received2002-02-14
Returned To Mfg2002-01-21
Model NumberNA
Catalog Number104467
Lot Number927570
ID NumberNA
Device AvailabilityR
Device Eval'ed by MfgrY
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key366534
ManufacturerBIOMET, INC.
Manufacturer AddressP.O. BOX 587 WARSAW IN 465810587 US
Baseline Brand NameMALLORY/HEAD PF RASP/PROV.
Baseline Generic NameRASP/PROVISIONAL
Baseline Model NoNA
Baseline Catalog No104467
Baseline IDNA
Baseline Device FamilyMALLORY/HEAD PF RASP PROV
Baseline Shelf Life [Months]NA
Baseline PMA FlagN
Baseline 510K PMNN
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptY


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2002-02-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.